Family History of Asthma in Infants with Bronchopulmonary Dysplasia
1 Pediatric Pulmonary Section, Department of Pediatrics and Division of Respiratory Sciences, Arizona Health Sciences Center, Tucson
The role of genetic or familial factors in the development of bronchopulmonary dysplasia (BPD) has not been evaluated. Detailed histories concerning asthma, allergy, and other lung diseases were obtained on first and second degree relatives of 17 infants with BPD, and 21 infants who had hyaline membrane disease but who did not develop BPD (HMD group). All infants in the BPD and HMD groups had hyaline membrane disease requiring assisted ventilation and greater than 50% inspired oxygen in the first five days of life. The diagnosis of HMD and BPD were made on radiographic and clinical criteria. Of the 17 infants with BPD, 13 had first or second degree relatives with physician-diagnosed asthma, compared to seven of 21 in the HMD group (P < .01). In addition, a significantly greater number of relatives of BPD infants (P < .005) had been hospitalized for their asthma as compared to HMD relatives. There were no differences between the groups for allergic rhinitis, eczema, bronchitis, emphysema, chronic cough, smoking, or wheezing with respiratory illnesses. These results suggest the possibility that airways with a genetic predisposition for reactivity may become highly reactive following neonatal lung disorders and their treatment. These irritable airways may then contribute to the development, or progression, or both of BPD.
Submitted on October 15, 1979Accepted on December 26, 1979
This article has been cited by other articles:
![]() |
A Greenough, J Alexander, S Burgess, J Bytham, P A J Chetcuti, J Hagan, W Lenney, S Melville, N J Shaw, J Boorman, et al. Preschool healthcare utilisation related to home oxygen status Arch. Dis. Child. Fetal Neonatal Ed., September 1, 2006; 91(5): F337 - F341. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.-N. Tsao, S.-C. Wei, Y.-N. Su, C.-N. Lee, H.-C. Chou, W.-S. Hsieh, and F.-J. Hsieh Placenta Growth Factor Elevation in the Cord Blood of Premature Neonates Predicts Poor Pulmonary Outcome Pediatrics, May 1, 2004; 113(5): 1348 - 1351. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Subramaniam, K. Sugiyama, D. H. Coy, Y. Kong, Y. E. Miller, P. F. Weller, K. Wada, E. Wada, and M. E. Sunday Bombesin-like Peptides and Mast Cell Responses: Relevance to Bronchopulmonary Dysplasia? Am. J. Respir. Crit. Care Med., September 1, 2003; 168(5): 601 - 611. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Cullen, L. J. Van Marter, E. N. Allred, M. Moore, R. B. Parad, and M. E. Sunday Urine Bombesin-like Peptide Elevation Precedes Clinical Evidence of Bronchopulmonary Dysplasia Am. J. Respir. Crit. Care Med., April 15, 2002; 165(8): 1093 - 1097. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Sheikh, D. Null, D. Gentile, C. Bimle, D. Skoner, K. McCoy, and R. Guthrie Urinary Leukotriene E4 Excretion During the First Month of Life and Subsequent Bronchopulmonary Dysplasia in Premature Infants Chest, June 1, 2001; 119(6): 1749 - 1754. [Abstract] [Full Text] [PDF] |
||||
![]() |
E Eber and M S Zach Paediatric origins of adult lung disease {bullet} 8: Long term sequelae of bronchopulmonary dysplasia (chronic lung disease of infancy) Thorax, April 1, 2001; 56(4): 317 - 323. [Full Text] |
||||









